Senzime Logo

Senzime

Develops neuromuscular monitoring systems to improve patient safety during and after surgery.

SEZI | ST

Overview

Corporate Details

ISIN(s):
SE0002478776
LEI:
549300JQF174JP0MM382
Country:
Sweden
Address:
ULLS VÄG 41, 756 51 Uppsala
Sector:
Manufacturing
Industry:
Manufacture of irradiation, electromedical and electrotherapeutic equipment

Description

Senzime is a medical technology company that develops and commercializes precision-based patient monitoring systems for the perioperative setting. The company's mission is to improve patient safety and outcomes during and after surgery by preventing anesthesia-related complications. Its core offering is the TetraGraph system, a quantitative neuromuscular monitor that utilizes proprietary algorithms and sensors to accurately assess neuromuscular blockade. By providing clinicians with real-time, objective data, Senzime's solutions facilitate personalized patient care and aim to establish a new standard of care in neuromuscular monitoring.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-29 08:30
Quarterly Report
Swedish 1.3 MB
2025-10-29 08:30
Quarterly Report
English 1.3 MB
2025-09-18 10:27
Major Shareholding Notification
Swedish 10.5 KB
2025-09-15 10:10
Major Shareholding Notification
Swedish 10.6 KB
2025-09-12 10:10
Major Shareholding Notification
Swedish 10.6 KB
2025-09-09 10:19
Major Shareholding Notification
Swedish 10.5 KB
2025-09-08 10:45
Major Shareholding Notification
Swedish 10.6 KB
2025-07-31 15:00
Declaration of Voting Results & Voting Rights Announcements
Förändrat antal aktier och röster i Senzime AB (publ)
Swedish 45.5 KB
2025-07-31 15:00
Declaration of Voting Results & Voting Rights Announcements
New number of shares and votes in Senzime AB (publ)
English 45.5 KB
2025-07-18 08:30
Earnings Release
Swedish 1.5 MB
2025-07-18 08:30
Quarterly Report
English 1.4 MB
2025-07-10 14:10
Share Issue/Capital Change
Senzime meddelar att den andra tranchen i den riktade emissionen om 110 MSEK ha…
Swedish 39.9 KB
2025-07-10 14:10
Share Issue/Capital Change
Senzime announces that the second tranche in the directed share issue of MSEK 1…
English 40.6 KB
2025-06-30 16:45
Post-Annual General Meeting Information
Kommuniké från EXTRA BOLAGSSTÄMMA i Senzime AB (publ)
Swedish 39.5 KB
2025-06-30 16:45
Share Issue/Capital Change
BULLETIN from EXTRAORDINARY GENERAL MEETING in Senzime AB (publ)
English 39.9 KB

Automate Your Workflow. Get a real-time feed of all Senzime filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Senzime

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Senzime via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2022-07-18 Fruholmen Invest AB Other Buy 7,000 104,300.00 SEK
2022-06-03 Fruholmen Invest AB Other Buy 2,000 35,600.00 SEK
2022-06-02 Fruholmen Invest AB Other Buy 15,000 265,500.00 SEK
2022-01-24 Fruholmen Invest AB Other Buy 10,000 195,000.00 SEK
2021-11-19 Fruholmen Invest AB Other Buy 10,000 202,200.00 SEK
2021-11-17 Fruholmen Invest AB Other Buy 15,000 304,800.00 SEK
2021-08-27 Fruholmen Invest AB Other Buy 240 5,112.00 SEK
2021-07-01 Lennart Kalén Other Buy 125,000 2,500,000.00 SEK
2021-07-01 Philip Siberg Other Sell 125,000 2,500,000.00 SEK
2021-05-24 Erik Bergman Other Buy 15,000 337,500.00 SEK

Peer Companies

Acarix Logo
AI-powered acoustic system for rapid, non-invasive rule-out of Coronary Artery Disease.
Sweden
ACARIX
ACCURAY INC Logo
Develops robotic and image-guided radiation therapy systems for cancer treatment.
United States of America
ARAY
Develops a pain-free breath device to measure blood glucose for diabetes management.
Poland
AME
Alpha Tau Medical Ltd. Logo
Developing Alpha DaRT, a precision alpha-radiation therapy designed to destroy solid tumors.
United States of America
DRTS
ANGIODYNAMICS INC Logo
Develops minimally invasive medical devices for vascular and oncology applications.
United States of America
ANGO
Apyx Medical Corp Logo
Develops helium plasma energy devices for cosmetic and surgical markets.
United States of America
APYX
Arcoma AB Logo
Develops and manufactures advanced digital X-ray and radiology solutions for global healthcare.
Sweden
ARCOMA
ASTERASYS Co., Ltd. Logo
Develops HIFU and body analysis devices for the global aesthetic and healthcare market.
South Korea
450950
Autonomix Medical, Inc. Logo
Developing a platform for real-time nerve mapping and targeted denervation to treat chronic pain.
United States of America
AMIX
Baird Medical Investment Holdings Ltd Logo
Develops microwave ablation devices for minimally invasive treatment of benign and malignant tumors.
United States of America
BDMD

Talk to a Data Expert

Have a question? We'll get back to you promptly.